Clinically silent Crohn's disease in a patient with Takayasu's arteritis unresponsive to conventional therapies

Rheumatol Int. 2013 Dec;33(12):3091-3. doi: 10.1007/s00296-012-2558-2. Epub 2012 Nov 10.

Abstract

Takayasu arteritis (TA) and Crohn's disease (CD) are chronic inflammatory diseases with granulomatous nature. Here, we report a case of TA with a silent course of CD who was refractory to corticosteroid and immunosuppressive treatments and improved with adalimumab therapy.

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Adrenal Cortex Hormones / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Colonoscopy
  • Comorbidity
  • Crohn Disease / diagnosis
  • Crohn Disease / drug therapy*
  • Crohn Disease / epidemiology*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Takayasu Arteritis / diagnosis
  • Takayasu Arteritis / drug therapy*
  • Takayasu Arteritis / epidemiology*
  • Treatment Failure
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab